Historical Valuation
CAMP4 Therapeutics Corp (CAMP) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 6.42. The fair price of CAMP4 Therapeutics Corp (CAMP) is between 9165.07 to 18725.13 according to relative valuation methord. Compared to the current price of 6.20 USD , CAMP4 Therapeutics Corp is Undervalued By 99.93%.
Relative Value
Fair Zone
9165.07-18725.13
Current Price：6.20
99.93%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
CAMP4 Therapeutics Corp (CAMP) has a current Price-to-Book (P/B) ratio of 0.00. Compared to its 3-year average P/B ratio of 2.72 , the current P/B ratio is approximately -100.00% higher. Relative to its 5-year average P/B ratio of 3.92, the current P/B ratio is about -100.00% higher. CAMP4 Therapeutics Corp (CAMP) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -150.46%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -70.35% , the current FCF yield is about -100.00% lower.
P/B
Median3y
2.72
Median5y
3.92
FCF Yield
Median3y
-150.46
Median5y
-70.35
Competitors Valuation Multiple
AI Analysis for CAMP
The average P/S ratio for CAMP competitors is 2.82, providing a benchmark for relative valuation. CAMP4 Therapeutics Corp Corp (CAMP.O) exhibits a P/S ratio of , which is -100% above the industry average. Given its robust revenue growth of -98.79%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CAMP
1Y
3Y
5Y
Market capitalization of CAMP increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CAMP in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CAMP currently overvalued or undervalued?
CAMP4 Therapeutics Corp (CAMP) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.00 is considered Undervalued compared with the five-year average of 6.42. The fair price of CAMP4 Therapeutics Corp (CAMP) is between 9165.07 to 18725.13 according to relative valuation methord. Compared to the current price of 6.20 USD , CAMP4 Therapeutics Corp is Undervalued By 99.93% .
What is CAMP4 Therapeutics Corp (CAMP) fair value?
CAMP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of CAMP4 Therapeutics Corp (CAMP) is between 9165.07 to 18725.13 according to relative valuation methord.
How does CAMP's valuation metrics compare to the industry average?
The average P/S ratio for CAMP's competitors is 2.82, providing a benchmark for relative valuation. CAMP4 Therapeutics Corp Corp (CAMP) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of -98.79%, this premium appears unsustainable.
What is the current P/B ratio for CAMP4 Therapeutics Corp (CAMP) as of Jan 09 2026?
As of Jan 09 2026, CAMP4 Therapeutics Corp (CAMP) has a P/B ratio of 0.00. This indicates that the market values CAMP at 0.00 times its book value.
What is the current FCF Yield for CAMP4 Therapeutics Corp (CAMP) as of Jan 09 2026?
As of Jan 09 2026, CAMP4 Therapeutics Corp (CAMP) has a FCF Yield of 0.00%. This means that for every dollar of CAMP4 Therapeutics Corp’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for CAMP4 Therapeutics Corp (CAMP) as of Jan 09 2026?
As of Jan 09 2026, CAMP4 Therapeutics Corp (CAMP) has a Forward P/E ratio of 0.04. This means the market is willing to pay $0.04 for every dollar of CAMP4 Therapeutics Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for CAMP4 Therapeutics Corp (CAMP) as of Jan 09 2026?
As of Jan 09 2026, CAMP4 Therapeutics Corp (CAMP) has a Forward P/S ratio of 0.00. This means the market is valuing CAMP at $0.00 for every dollar of expected revenue over the next 12 months.